ArticleNature cancer2022

Therapeutic targeting of the mevalonate-geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancer.

Chenchen Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.